Strategies for ensuring diversity, inclusion, and meaningful participation in clinical trials : proceedings of a workshop

著者

書誌事項

Strategies for ensuring diversity, inclusion, and meaningful participation in clinical trials : proceedings of a workshop

Karen M. Anderson and Steve Olson, rapporteurs ; Roundtable on the Promotion of Health Equity and the Elimination of Health Disparities, Board on Population Health and Public Health Practice, Health and Medicine Division, The National Academies of Sciences, Engineering, Medicine

National Academies Press, c2016

大学図書館所蔵 件 / 1

この図書・雑誌をさがす

注記

Includes bibliographical references (p. 53-54)

内容説明・目次

内容説明

Even as the U.S. population becomes steadily more diverse, minorities and women remain underrepresented in clinical trials to develop new drugs and medical devices. Although progress in increasing minority participation in clinical trials has occurred, participation rates do not fully represent the overall population of minorities in the United States. This underrepresentation threatens the health of both these populations and the general population, since greater minority representation could reveal factors that affect health in all populations. Federal legislation has sought to increase the representation of minorities and women in clinical trials, but legislation by itself has not been sufficient to overcome the many barriers to greater participation. Only much broader changes will bring about the meaningful participation of all population groups in the clinical research needed to improve health. To examine the barriers to participation in clinical trials and ways of overcoming those barriers, the National Academies of Sciences, Engineering, and Medicine held a workshop in April 2015. This publication summarizes the presentations and discussions from the workshop. Table of Contents Front Matter 1 Introduction and Highlights of the Workshop 2 Historical Perspectives and Context 3 Scientific Issues: Clinically Meaningful Inclusion 4 Recruitment and Retention Issues: Patient, Provider, Institutional, and System Barriers 5 Potential Best Practices and Policy Options References Appendix A: Workshop Agenda Appendix B: Speaker Biographical Sketches Appendix C: Statement of Task

目次

  • 1 Front Matter
  • 2 1 Introduction and Highlights of the Workshop
  • 3 2 Historical Perspectives and Context
  • 4 3 Scientific Issues: Clinically Meaningful Inclusion
  • 5 4 Recruitment and Retention Issues: Patient, Provider, Institutional, and System Barriers
  • 6 5 Potential Best Practices and Policy Options
  • 7 References
  • 8 Appendix A: Workshop Agenda
  • 9 Appendix B: Speaker Biographical Sketches
  • 10 Appendix C: Statement of Task

「Nielsen BookData」 より

詳細情報

ページトップへ